Partners of CLIO Consortium held the first "Kick-off " Meeting to set up the first steps for the implementation of the CLIO project . 3rd-4th February 2014. Budapest, Hungary.
Clinical LighPath imaging in Poland
More details here: https://www.lightpointmedical.com/posts/news/first-lightpath-scans-performed-in-poland/
From the CLI Project Unto the Surgery Rooms
Further Applications and Installations of the Medical Devices developed in the CLI Project
The CE-marked LightPath ® medical device has been installed in leading oncology centres worldwide
-University Hospital Essen, Germany
-Guy`s and St Thomas’ Hospital London, UK
-University Hospital Twente, The Netherlands
-University of Cambridge, Cambridge, UK
The HARLI ™ hand-held experimental medical imaging system has been installed in
-University of Wisconsin School of Medicine and Public Health, Madison, USA
-University of Cambridge, Cambridge, UK
-Leiden University Medical Centre, Leiden, The Netherlands
The products are now featured at Lightpoint`s website. The Consortium results have made a significant contribution to everyday oncology patient care.
Review meeting
The Consortium has had its Final Review Meeting in Budapest, the 26th of January 2017. Pre-clinical and clinical results have been reviewed. This was combined with a site visit. The outlook of Partners’ collaboration after the project, for the exploitation of results and medical device products in their market phase was also drawn up.
Because of the Project, Lightpoint Medical has submitted four Patent Applications and three Trademark protections. Some of these are currently available at their respective Patent Authorities (WIPO and the Intellectual Property Office of the UK).
Awards
Lightpoint Achieves Prestigious Engineering Awards with the LighPath medical imaging system:
British Engineering Excellence Awards – Electronics Product (London, UK, 2016): Winner
British Engineering Excellence Awards – Grand Prix (London, UK, 2016): Winner
Meetings
During the Project the Consortium had a high number of meetings. Those meetings among Consortium Partners were essential in overall and technology planning, device tests, trainings for the pre-clinical and experimental clinical use of the prototype imaging systems and scientific data assessment.